Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Series A Preferred Stock	Common Shares	Treasury Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2024		$ 9,879	$ (1,199,337)	$ 36,399,897	$ (23,310,777)	$ 11,899,662
Balance (in Shares) at Dec. 31, 2024		9,878,950
Balance (in Shares) at Dec. 31, 2024			(641,963)
Stock-based compensation expense				167,629		167,629
Issuance of Series A Preferred Stock	$ 4,000			8,196,000		8,200,000
Issuance of Series A Preferred Stock (in Shares)	4,000,000
Net income (loss)					808,530	808,530
Balance at Mar. 31, 2025	$ 4,000	$ 9,879	$ (1,199,337)	44,763,526	(22,502,247)	21,075,821
Balance (in Shares) at Mar. 31, 2025	4,000,000	9,878,950
Balance (in Shares) at Mar. 31, 2025			(641,963)
Balance at Dec. 31, 2025	$ 4,000	$ 9,879	$ (1,500,385)	44,939,747	(25,267,313)	$ 18,185,928
Balance (in Shares) at Dec. 31, 2025	4,000,000	9,878,950
Balance (in Shares) at Dec. 31, 2025			(793,221)			793,221
Stock-based compensation expense				23,556		$ 23,556
Repurchases of common stock			$ (83,491)			(83,491)
Repurchases of common stock (in Shares)			(50,000)
Net income (loss)					(660,214)	(660,214)
Balance at Mar. 31, 2026	$ 4,000	$ 9,879	$ (1,583,876)	$ 44,963,303	$ (25,927,527)	$ 17,465,779
Balance (in Shares) at Mar. 31, 2026	4,000,000	9,878,950
Balance (in Shares) at Mar. 31, 2026			(843,221)			843,221